Migraine pain management presents complex challenges for both practitioners and researchers, requiring a deep understanding of evolving treatments.
Explore groundbreaking insights into migraine treatment in this exclusive three-part webinar series, hosted by leading experts in the field. This series accompanies the upcoming Elsevier publication, Migraine Pain Management, offering a deep dive into the latest scientific advancements, therapeutic approaches and non-pharmacological treatments for migraine sufferers.
Whether you're a healthcare professional, researcher or simply interested in the future of migraine management, these sessions provide invaluable knowledge directly from the book’s expert contributors.
Explore groundbreaking insights into migraine treatment in this exclusive three-part webinar series, hosted by leading experts in the field. This series accompanies the upcoming Elsevier publication, Migraine Pain Management, offering a deep dive into the latest scientific advancements, therapeutic approaches and non-pharmacological treatments for migraine sufferers.
Whether you're a healthcare professional, researcher or simply interested in the future of migraine management, these sessions provide invaluable knowledge directly from the book’s expert contributors.
Mon, Sep. 30, 2024 · 10:00 am (EDT)
Kickstart the series with an in-depth exploration of the science behind migraines. Dr. Stephen Shrewsbury introduces the research featured in Migraine Pain Management, covering the latest findings on migraine mechanisms and management strategies. Joining him are experts in comorbidities, neuromodulation, and comprehensive migraine management tools.
Principal at Shrewd Consulting LLC and previously Chief Medical Officer at Impel Pharmaceuticals and at MAP Pharmaceuticals, and editor of Migraine Pain Management
Professor, Sapienza Università di Roma, Rome, Italy
Gianluca Coppola, MD, PhD, is associate professor of Neurology at Sapienza University of Rome. He is Co-chair of the Membership Committee of the International Headache Society, member of the Board at Large of the European Headache Federation and of the Study Center of the Italian Society for the Study of Headache. His research interests include the use of electrophysiology and neuroimaging techniques to understand primary headaches pathophysiology.
Wed, Oct. 23, 2024 · 11:00 am (EDT)
This session covers the evolution of pharmacological treatments for migraines. Learn about the history and future of migraine medications, from ergots and triptans to the latest innovations such as gepants, CGRP antibodies, and Delta opioid receptor therapies. Discover how the latest routes of administration are transforming treatment options.
Principal at Shrewd Consulting LLC and previously Chief Medical Officer at Impel Pharmaceuticals and at MAP Pharmaceuticals, and editor of Migraine Pain Management
Stephen B. Shrewsbury, spent his first 13 years in UK clinical practice in primary care and pulmonary medicine, before joining Glaxo and accepting honorary clinical positions at both the Department of Child Health at Southampton University and then the Department of Allergy and Clinical Immunology at the National Heart and Lung Institute in London. In 2000, he moved to the US and led Glaxo’s inhaled fluticasone and Upper Respiratory Inflammatory Disorders programs before moving to the west coast to lead Chiron’s Inhaled Antibiotic Core Team. Steve has held the CMO position in several biotech companies including MAP Pharmaceuticals, Adamas Pharmaceuticals, AVI BioPharma (now Sarepta Therapeutics), Aquinox Pharmaceuticals, and lastly at Impel Pharmaceuticals where he led drug-device combination product programs delivering drugs to the upper nasal space, in migraine, acute agitation and Parkinson’s disease and now runs his Shrewd Consulting business. Dr. Shrewsbury qualified MB ChB in Medicine from The University of Liverpool, UK.
Professor, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University in Philadelphia, PA; one of the few academic headache centers in the country. Involved with migraine research and clinical trials. Author of over 500 peer-reviewed publications.
A Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society (AHS). Served the AHS as President, Treasurer, and Board of Directors member. He is the 2016 Lifetime Achievement Award recipient by AHS, the International Headache Society Lifetime Achievement Award 2023, and the Headache Cooperative of the Northeast Lifetime Achievement Award 2024. Chairman within the World Federation of Neurology and President of the Philadelphia Headache Society.
Dr. Silberstein is the senior editor of the 8th edition (and the upcoming 9th edition) of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache, Cephalalgia, Acta Neurologica Scandanavia, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management.
A Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society (AHS). Served the AHS as President, Treasurer, and Board of Directors member. He is the 2016 Lifetime Achievement Award recipient by AHS, the International Headache Society Lifetime Achievement Award 2023, and the Headache Cooperative of the Northeast Lifetime Achievement Award 2024. Chairman within the World Federation of Neurology and President of the Philadelphia Headache Society.
Dr. Silberstein is the senior editor of the 8th edition (and the upcoming 9th edition) of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache, Cephalalgia, Acta Neurologica Scandanavia, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management.
Tue, Nov. 12, 2024 · 10:00 am (EST)
Explore non-pharmacological treatments that have historically offered promising results for managing migraines and the contemporary research supporting them. This session delves into innovative approaches like phototherapy, nutraceuticals, and mindfulness practices, providing a comprehensive look at alternative options to medication. Learn how to incorporate these methods into a migraine management toolbox for improved patient outcomes.
Principal at Shrewd Consulting LLC and previously Chief Medical Officer at Impel Pharmaceuticals and at MAP Pharmaceuticals, and editor of Migraine Pain Management
Stephen B. Shrewsbury, spent his first 13 years in UK clinical practice in primary care and pulmonary medicine, before joining Glaxo and accepting honorary clinical positions at both the Department of Child Health at Southampton University and then the Department of Allergy and Clinical Immunology at the National Heart and Lung Institute in London. In 2000, he moved to the US and led Glaxo’s inhaled fluticasone and Upper Respiratory Inflammatory Disorders programs before moving to the west coast to lead Chiron’s Inhaled Antibiotic Core Team. Steve has held the CMO position in several biotech companies including MAP Pharmaceuticals, Adamas Pharmaceuticals, AVI BioPharma (now Sarepta Therapeutics), Aquinox Pharmaceuticals, and lastly at Impel Pharmaceuticals where he led drug-device combination product programs delivering drugs to the upper nasal space, in migraine, acute agitation and Parkinson’s disease and now runs his Shrewd Consulting business. Dr. Shrewsbury qualified MB ChB in Medicine from The University of Liverpool, UK.
Professor, Mayo Clinic, Phoenix, Arizona, USA
Dr. Amaal J. Starling is an Associate Professor of Neurology in the Mayo Clinic College of Medicine and Science. She joined Mayo in 2012 and is currently a board-certified Consultant within the Department of Neurology. She is presently the Program Director for the Headache Medicine Fellowship and is Program Director for the Transitional Year Residency Program in the Mayo Clinic College of Medicine and Science – Arizona Campus.
Dr. Starling received her M.D. degree from Drexel University College of Medicine in Philadelphia. She completed a Transitional Year Residency, a Neurology Residency, and a Headache Fellowship at the Mayo Clinic College of Medicine in Scottsdale, Arizona. She was also the External Chief Resident for the Department of Neurology, Mayo Clinic, Arizona.
She is a Fellow of the American Academy of Neurology (AAN) and the American Headache Society (AHS). She is an active member American Medical Association and the American Pain Society. Dr. Starling serves on the advisory boards of Alder, AMGEN, Eli Lilly and Company, the International Concussion Society (ICS), NeurologyLive, the NDPH Research Foundation, and the United Council for Neurologic Subspecialties. In addition, she has served as the Co-Chair of the American Headache and Migraine Association, Chair of the New Investigator and Trainee Special Interest Section of the AHS. She has been an invited speaker to many international, national, and regional meetings and has been a perennial speaker at the AHS Annual Meeting in Scottsdale, Arizona. Her many honors include the AHS Above and Beyond Award for Service, Manfred D. Muenter Award for Excellence in Clinical Neurology, the AAN Annual Meeting Residency Scholarship, the 2012 Spirit of Mayo Clinic Award, and the Mayo Brothers Distinguished Fellowship Award. Dr. Starling’s most recent accolades include the Women Leading in Neurology recognition from the AAN, Super Supporter Award from Miles for Migraine, and the Outstanding Emerging Educator from the Mayo Clinic College of Medicine and Science.
Dr. Starling has over 70 peer-reviewed publications and abstracts related to her fields of interest which include migraine, concussion, posttraumatic headache, trigeminal autonomic cephalalgias, secondary headaches, telemedicine and teleconcussion, neurology resident education, and professionalism and clinical ethics. She is an active participant and member of many educational and departmental committees within Mayo Clinic.
Dr. Starling received her M.D. degree from Drexel University College of Medicine in Philadelphia. She completed a Transitional Year Residency, a Neurology Residency, and a Headache Fellowship at the Mayo Clinic College of Medicine in Scottsdale, Arizona. She was also the External Chief Resident for the Department of Neurology, Mayo Clinic, Arizona.
She is a Fellow of the American Academy of Neurology (AAN) and the American Headache Society (AHS). She is an active member American Medical Association and the American Pain Society. Dr. Starling serves on the advisory boards of Alder, AMGEN, Eli Lilly and Company, the International Concussion Society (ICS), NeurologyLive, the NDPH Research Foundation, and the United Council for Neurologic Subspecialties. In addition, she has served as the Co-Chair of the American Headache and Migraine Association, Chair of the New Investigator and Trainee Special Interest Section of the AHS. She has been an invited speaker to many international, national, and regional meetings and has been a perennial speaker at the AHS Annual Meeting in Scottsdale, Arizona. Her many honors include the AHS Above and Beyond Award for Service, Manfred D. Muenter Award for Excellence in Clinical Neurology, the AAN Annual Meeting Residency Scholarship, the 2012 Spirit of Mayo Clinic Award, and the Mayo Brothers Distinguished Fellowship Award. Dr. Starling’s most recent accolades include the Women Leading in Neurology recognition from the AAN, Super Supporter Award from Miles for Migraine, and the Outstanding Emerging Educator from the Mayo Clinic College of Medicine and Science.
Dr. Starling has over 70 peer-reviewed publications and abstracts related to her fields of interest which include migraine, concussion, posttraumatic headache, trigeminal autonomic cephalalgias, secondary headaches, telemedicine and teleconcussion, neurology resident education, and professionalism and clinical ethics. She is an active participant and member of many educational and departmental committees within Mayo Clinic.
